Dick Uihlein
Fortuna: 48 M $ al 30/06/2026
Fortuna: 48 M $ al 30/06/2026
Richard E.
Uihlein is the founder of Uline, Inc., founded in 1980, where he holds the title of Chief Executive Officer.
Mr. Uihlein currently holds the position of Chairman at Galectin Therapeutics, Inc., starting in 2018.
Mr. Uihlein completed undergraduate education at Stanford University in 1967.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GALECTIN THERAPEUTICS INC. 15,73 % | 16/01/2026 | 10.360.386 ( 15,73 % ) | 48 M $ | 30/06/2026 |
GALECTIN THERAPEUTICS INC. 28,41 % | 22/09/2025 | 50 ( 28,41 % ) | 232 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | Presidente | 04/06/2018 |
Uline, Inc.
Uline, Inc. Wholesale DistributorsDistribution Services Distributes shipping, industrial and packing materials | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Galectin Therapeutics, Inc.
Galectin Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs to combat various diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uline, Inc.
Uline, Inc. Wholesale DistributorsDistribution Services Distributes shipping, industrial and packing materials | Distribution Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.